跳至主要内容
附件 II 条目 992 CMR已修订 15 十月 2010

Resorcinol diglycidyl ether

Resorcinol diglycidyl ether 在附件 II 中被列为在欧盟市场上市的化妆品的禁用物质。

禁用物质— 附件 II, 欧盟法规 1223/2009
条目: 992
CMR

记录详情

化学名称

Resorcinol diglycidyl ether

监管信息

关键数据

附件
条目编号
992

化学身份与性质

CAS 101-90-6 的 PubChem 二维化学结构
CAS 101-90-6PubChem CID 7586

Resorcinol diglycidyl ether

Diglycidyl resorcinol ether is an aromatic ether. — ChEBI

IUPAC 名称
2-[[3-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane
分子式
C12H14O4
分子量
222.24 g/mol
精确质量
222.08920892 Da
XLogP3
1.2
拓扑极性表面积
43.5 Ų
氢键供体
0
氢键受体
4
共价单元
1
已定义的立体中心
0

又称

DIGLYCIDYL RESORCINOL ETHERResorcinyl diglycidyl ether1,3-Bis(2,3-epoxypropoxy)benzenem-Bis(2,3-epoxypropoxy)benzene1,3-Diglycidyloxybenzenem-Bis(glycidyloxy)benzeneDiglycidyl ether of resorcinolAraldite ERE 1359
另有 16 个已报告名称
Benzene, m-bis(2,3-epoxypropoxy)-Resorcinol bis(2,3-epoxypropyl) ethermeta-Bis(glycidyloxy)benzeneNCI-C54966Resorcinol glycidyl ether2,2'-(1,3-Phenylenebis(oxymethylene))bisoxiraneDiglycidylresorcinol etherERE 1359RDGEOxirane, 2,2'-[1,3-phenylenebis(oxymethylene)]bis-FXN2Y6QZ2Wmeta-Bis(2,3-epoxypropoxy benzene)NSC-76621Oxirane, 2,2'-(1,3-phenylenebis(oxymethylene))bis-2-((3-(oxiran-2-ylmethoxy)phenoxy)methyl)oxiraneresorcinol bis(2,3-epoxypropyl)ether
外部数据库标识符

来自其他科学数据库的证据

EMBL-EBI ChEBI
标识符精确匹配CHEBI:82318

Diglycidyl resorcinol ether

配方
C12H14O4
平均质量
222.240 g/mol
单同位素质量
222.08921 Da
形式电荷
0
  • aromatic ether — is a (CHEBI:35618)
  • aromatic ether — is a (CHEBI:35618)
来自此来源的交叉引用
  • CAS: 101-90-6 — KEGG COMPOUND
  • MANUAL_X_REF: C19228 — KEGG COMPOUND

映射方: Exact CAS cross-reference in the ChEBI compound record. 检索时间: 2026-08-31. 打开来源记录

NIH PubChem PUG-View
标识符精确匹配7586

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. IMMEDIATELY call a hospital or poison control center even if no symptoms (such as redness or irritation) develop. IMMEDIATELY transport the victim to a hospital for treatment after washing the affected areas.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknow 来源: CAMEO Chemicals
  • Signal: Danger 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H311: Toxic in contact with skin [Danger Acute toxicity, dermal]; H315: Causes skin irritation [Warning Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H350: May cause cancer [Danger Carcinogenicity]; H412: Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P203, P261, P262, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P316, P318, P321, P330, P332+P317, P333+P317, P337+P317, P361+P364, P362+P364, P405, and P501 (click each P-code to see the statement) 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Signal: Danger 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H311 (26.8%): Toxic in contact with skin [Danger Acute toxicity, dermal]; H312 (73.2%): Harmful in contact with skin [Warning Acute toxicity, dermal]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H341 (100%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H350 (26.8%): May cause cancer [Danger Carcinogenicity]; H351 (73.2%): Suspected of causing cancer [Warning Carcinogenicity]; H372 (22.6%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H373 (22.6%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]; H412 (94.6%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P260, P261, P262, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P316, P317, P318, P319, P321, P330, P332+P317, P333+P317, P337+P317, P361+P364, P362+P364, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 504 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Signal: Danger 来源: NITE-CMC
  • GHS Hazard Statements: H350: May cause cancer [Danger Carcinogenicity] 来源: NITE-CMC
  • Precautionary Statement Codes: P203, P280, P318, P405, and P501 (click each P-code to see the statement) 来源: NITE-CMC
  • Signal: Warning 来源: NITE-CMC
  • GHS Hazard Statements: H315: Causes skin irritation [Warning Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335: May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H351: Suspected of causing cancer [Warning Carcinogenicity] 来源: NITE-CMC

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
EMBL-EBI ChEBI精确匹配2026-08-31
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

该记录的直接匹配结果有限,因此同时显示附件 II 中的相邻条目。

附件 II 995
同一附件中的相邻记录

4-Nitrosophenol

CAS: 104-91-6
EC: 203-251-6
附件 II 996
同一附件中的相邻记录

Carbendazim

CAS: 10605-21-7
EC: 234-232-0

附件 II 对 Resorcinol diglycidyl ether 意味着什么

Resorcinol diglycidyl ether 被列为欧盟化妆品法规 1223/2009 附件 II 中的禁用物质,不得有意添加。第 17 条另行规定了在良好生产规范下技术上不可避免、且符合第 3 条安全要求的非有意微量存在的情形。

配方师必须筛查其成分和原料,确保均不含该物质。供应商应在被要求时提供证明不含该物质的文件。

本页还显示 12 条相关附件记录,其标识符、附件逻辑或命名模式存在重叠。

合规核查清单

  • 核实该物质不存在于所有原料和成品配方中。
  • 向原料供应商索取不含该物质的确认函或 CoA。
  • 将筛查结果记录在产品信息档案 (PIF) 中。
  • 该物质具有 CMR 分类。使用前请查看上方的 CMR 表,并核实现行附件 II/III 状态。

常见问题

是。Resorcinol diglycidyl ether 列于欧盟化妆品法规 1223/2009 的附件 II,禁止作为化妆品成分有意添加。第 17 条对在良好生产规范下技术上不可避免的非有意微量存在规定了狭窄的例外,前提是产品仍符合第 3 条的安全要求。

CAS 101-90-6 是化学文摘社 (Chemical Abstracts Service) 分配给 Resorcinol diglycidyl ether 的唯一数字标识符。在化妆品合规工作中,CAS 编号用于在监管数据库、原料规格书和安全评估报告之间交叉引用该物质。如果同一物质在不同条件下或不同附件中出现,多个欧盟附件条目可能共用同一 CAS 编号。

Resorcinol diglycidyl ether 在欧盟 CLP 法规下具有 CMR(致癌、致突变或生殖毒性)分类。根据欧盟化妆品法规 1223/2009 第 15 条,1A 类或 1B 类 CMR 物质禁止用于化妆品,除非被特别允许。2 类 CMR 物质只有经 SCCS 评估为安全才可使用。使用前请务必核实现行附件状态及任何适用的豁免。

使用本站的 INCI 检查器工具粘贴您的完整成分表 (INCI),并对照所有附件 II–VI 条目进行扫描。该工具会突出显示与限用、禁用或致敏原标记记录相匹配的成分。这有助于对成品配方或原料声明进行快速合规筛查。

附件 II 记录 Resorcinol diglycidyl ether 的来源说明

本页概述欧盟委员会公开化妆品资料中 Resorcinol diglycidyl ether 的一条附件 II 记录,并在可用时补充关联的清单或标识符匹配。

请使用本记录页面查看 Resorcinol diglycidyl ether 的附件 II 条件,但任何最终监管决定都应对照现行官方附件措辞和来源文件确认。

工具与后续步骤

检查您的配方

粘贴完整的 INCI 成分表,一次性检出 Resorcinol diglycidyl ether 及其他被标记的欧盟附件记录。

INCI 检查器

条目对比

将 Resorcinol diglycidyl ether 与另一条附件记录并排对比,查看限制、浓度和附件归属的差异。

对比

浏览附件

查看附件 II 中的所有记录,并对比该附件中各物质的监管条件。

打开附件 II